Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used